In the News

386 News Items found
Microscopy image showing a quiescent cluster of lung adenocarcinoma tumor cells with low STING expression.
A team of scientists at the Sloan Kettering Institute has identified the STING cellular signaling pathway as a key player in keeping dormant cancer cells from progressing into aggressive tumors months, or even years, after they’ve escaped from a primary tumor.
SKI scientists David Scheinberg and Derek Tan
These souped-up versions may help overcome some limitations of existing CAR T cells.
Memorial Sloan Kettering surgeon Prasad Adusumilli
Q&A
A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.
A Fred’s Team runner giving a high five
Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.
a lab coat hangs in an MSK lab
New MSK research discovers a new approach that could prevent chemotherapy-related leukemia; shows how monoclonal antibodies can turn neutrophils into cancer killers; helps develop sensitive CAR T cells that target CD70 antigen to destroy cancer cells; and uses single-cell studies to yield new clues about a rare, aggressive pediatric sarcoma.
Female doctor in white coat examining patient with stethoscope.
Feature
MSK leads the way in optimizing radiation treatment for breast cancer patients.
José Baselga
Announcement
At the 2016 American Association for Cancer Research (AACR) conference, there were clear signs that cancer treatment is evolving from a slash-and-burn method to a more precisely targeted, intelligent approach.
Immune cells surrounding a cancer cell
In the Lab
Scientists have learned that cutting a T cell’s brakes can have unexpected consequences.
ContactTracing graphic
A collaboration between MSK and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.
Radiation oncologist Josh Yamada
Learn how radiation oncologists at Memorial Sloan Kettering are making radiation therapy for metastatic cancer more effective, with fewer side effects, including a new advance called ECHO.